Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 22.4.2025AstraZeneca AB (AZC)9744DSaphnelo 300 mg koncentrát na infúzny roztok (con inf 1x2 ml/300 mg (liek.inj.skl.))11.4.2025U
 22.4.2025B.Braun Melsungen AG (BME)49675Propofol-Lipuro 1 % (10 mg/ml) (emu ijf 5x20 ml/200 mg (amp.skl.))22.4.2025R
 21.4.2025Indivior Europe Limited (IIV-IE)36928Suboxone 2 mg/0,5 mg sublingválne tablety (tbl slg 7x2 mg/0,5 mg (blis.papier/Al/nylon/Al/PVC))15.2.2025R
 17.4.2025B.Braun Melsungen AG (BME)3644DIbuprofen B. Braun 200 mg (sol inf 10x50 ml (fľ.LDPE))1.8.2025Z
 17.4.2025Zentiva, k.s. (ZNT-1)84758Rosucard 10 mg filmom obalené tablety (tbl flm 90x10 mg (blis.OPA/Al/PVC//Al))17.4.2025O
 17.4.2025Zentiva a.s. (ZNT-SK-2)36130Citalec 10 Zentiva (tbl flm 30x10 mg (blis.PVC/PVDC/Al))17.4.2025O
 17.4.2025KRKA, d.d., Novo mesto (KRK-2)9098ATenloris 100 mg/5 mg filmom obalené tablety (tbl flm 30x100 mg/5 mg (blis.OPA/Al/PVC/Al))22.4.2025O
 17.4.2025KRKA, d.d., Novo mesto (KRK-2)30031Doreta 75 mg/650 mg filmom obalené tablety (tbl flm 60x75 mg/650 mg (blis.PVC/PVDC/Al))22.4.2025O
 17.4.2025KRKA, d.d., Novo mesto (KRK-2)4010BDulsevia 30 mg tvrdé gastrorezistentné kapsuly (cps end 28x30 mg (blis.OPA/Al/[HDPE/PE+DES z CaO/HDPE]/Al/PE))22.4.2025R
 17.4.2025KRKA, d.d., Novo mesto (KRK-2)95363Tanyz (cps mdd 100x0,4 mg (blis.PVC/PE/PVDC/Al))22.4.2025O
 17.4.2025KRKA, d.d., Novo mesto (KRK-2)86846Emanera 20 mg tvrdé gastrorezistentné kapsuly (cps end 28x20 mg (blis.OPA/Al/PE+DES film/Al/PE))22.4.2025O
 17.4.2025KRKA, d.d., Novo mesto (KRK-2)2039CTeldipin 80 mg/5 mg tablety (tbl 90x80 mg/5 mg (blis.OPA/Al/PVC/Al))22.4.2025O
 17.4.2025KRKA, d.d., Novo mesto (KRK-2)8029AOprymea 0,52 mg tablety s predĺženým uvoľňovaním (tbl plg 30x0,52 mg (blis.OPA/Al/vysušovadlo/PE/Al))22.4.2025O
 17.4.2025KRKA, d.d., Novo mesto (KRK-2)9538DCo-Prenessa Neo 10 mg/2,5 mg tablety (tbl 30x10 mg/2,5 mg (blis.OPA/Al/PVC//Al))22.4.2025O
 17.4.2025KRKA, d.d., Novo mesto (KRK-2)9932DAmlessa Neo 10 mg/10 mg tablety (tbl 30x10 mg/10 mg (blis.OPA/Al/PVC//Al))22.4.2025O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)